Taihill Venture

Taihill Venture is a venture capital firm established in 2017 and located in Cambridge, Massachusetts. The firm focuses on investing in early-stage technology startups and is sector-agnostic, meaning it does not limit its investments to specific industries. Taihill Venture seeks to support disruptive and impactful companies that have the potential to drive significant innovation and change across various sectors.

Raed Attia

Venture Partner

Mikel Badiola

Partner

Jingjing Chai

Venture Partner

Gray Chen

Co-Founding Partner and Venture Partner

Ricki Huang

Venture Partner

Diana Liu MD

Venture Partner

Yubo Ruan

Venture Partner

Fawaz Al Shawwa

Venture Partner

Tianmeng Xu

Partner

Tianyi (Sky) Yu

Partner

Xudong Lv Ph.D

Venture Partner

Huiliang Wang Ph.D

Venture Partner

58 past transactions

Bot Auto

Seed Round in 2024
Bot Auto, headquartered in Houston, Texas, operates a fleet of Level 4 autonomous trucks. It provides Transportation as a Service (TaaS) to freight customers, leveraging AI-driven technology to address industry challenges such as driver shortages and enhance logistics efficiency. The company's team comprises experienced leaders, top-tier engineers, and industry veterans, positioning it to commercialize autonomous trucking on a large scale.

Kano Therapeutics

Seed Round in 2024
Kano Therapeutics is a biotechnology company dedicated to advancing genome-editing therapies through innovative biomaterials. The company specializes in the correction of gene-length DNA using circular single-stranded DNA biomaterials, providing a comprehensive platform that integrates manufacturing, application, and computational tools for genetic payload development. By leveraging DNA nanotechnology and synthetic biology, Kano Therapeutics designs and engineers novel gene vectors that effectively carry genetic information. This enables researchers and pharmaceutical companies to enhance gene delivery methods and develop vaccine constructs, ultimately supporting the progression of genetic cures in a safe and efficient manner.

DappOS

Series A in 2024
DappOS is an innovative company focused on enhancing the usability and accessibility of decentralized applications (dApps) within the blockchain ecosystem. By developing a unified operating protocol, DappOS creates a user-friendly layer that simplifies interactions between users and various blockchain infrastructures, including public blockchains and cross-chain bridges. This approach allows for intuitive user interfaces and streamlined experiences, making dApps as easy to use as mobile applications. DappOS aims to lower the technical barriers associated with blockchain technology, facilitating greater mass adoption of decentralized applications and contributing to a more interconnected and user-centric blockchain environment.

BitEnergy AI

Pre Seed Round in 2024
BitEnergy AI is a technology company specializing in the development of advanced AI inference technology. This innovation consumes just one-tenth the energy of existing solutions, making it a more sustainable and cost-effective option for artificial intelligence applications. The company's offerings include novel neural network architectures, neuro-symbolic large models, and first-principle grounded tools. These enable clients to integrate their models with knowledge graphs and reasoning engines, leading to precise data retrieval, transparent decision-making, reduced AI costs, and streamlined processes.

HopeAI

Pre Seed Round in 2024
HopeAI accelerates clinical trials using AI. It provides an AI copilot for clinical development teams, offering real-time evidence and insights to optimize trial design and execution. This enhances success rates and speeds up time to market for life-saving medicines.

DappOS

Seed Round in 2023
DappOS is an innovative company focused on enhancing the usability and accessibility of decentralized applications (dApps) within the blockchain ecosystem. By developing a unified operating protocol, DappOS creates a user-friendly layer that simplifies interactions between users and various blockchain infrastructures, including public blockchains and cross-chain bridges. This approach allows for intuitive user interfaces and streamlined experiences, making dApps as easy to use as mobile applications. DappOS aims to lower the technical barriers associated with blockchain technology, facilitating greater mass adoption of decentralized applications and contributing to a more interconnected and user-centric blockchain environment.

Collov

Series A in 2023
Collov is a software-as-a-service company that offers a virtual interior design and shopping platform, focusing on enhancing spatial intelligence. The company utilizes artificial intelligence and virtual reality technologies to transform residential spaces, providing users with an interactive experience in home decoration. By leveraging an AI algorithm-driven e-commerce platform, Collov enables clients to access a diverse array of interior design solutions tailored to homeowners' needs. This innovative approach facilitates a seamless integration of design and shopping, making it easier for users to visualize and implement their interior design choices.

Perceptive

Series A in 2023
Perceptive is a company focused on the design, development, and manufacturing of advanced medical devices specifically for the dentistry industry. It specializes in automated robotics technology that aims to revolutionize dental care by making image-guided robotic restorative dentistry a standard practice. The company's innovative technology enhances the precision of dental procedures, allowing dentists to more accurately identify and remove tooth decay, ultimately leading to superior restorations for patients. By improving the efficiency of dental care, Perceptive enables practitioners to deliver high-quality services at a lower cost and in a reduced timeframe, thereby increasing clinical capacity and advancing the standard of care in dentistry.

Kebotix

Venture Round in 2023
Kebotix, Inc. is a company focused on revolutionizing the materials discovery and production industry through the integration of artificial intelligence, machine learning, and robotic automation. Founded in 2017 and headquartered in Cambridge, Massachusetts, Kebotix has developed a platform that significantly accelerates the research and development process, condensing it from years into mere months. This innovative approach enables scientists and researchers to discover new chemicals and materials, enhancing public health and sustainability while promoting green chemistry solutions that reduce hazardous substance production. The company provides its partners with access to advanced digital research and development tools, facilitating materials innovation and the creation of formulations tailored to specific desired properties.

Acrobat Genomics

Pre Seed Round in 2023
Acrobat Genomics specializes in developing precise, high-throughput CRISPR-based gene editing technologies for creating innovative therapies.

Valley

Pre Seed Round in 2022
Valley creates a Digital Silicon Valley to assist users in creating, managing, and maximizing their startup communities. Users of Valley can create their startup stories, and the company shares the best ones with its investor network every two weeks via a newsletter that is sent to over 500 VCs and angel investors from companies like Sequoia, Antler, LAUNCH, NFX, and others.

Axoft

Seed Round in 2022
Axoft develops implantable, bioinspired electronics that enable long-term communication with the nervous system to improve clinical outcomes and overall health. The company creates ultra-flexible plastic mesh implants housing multiple sensors that closely match brain tissue mechanics, aiming to reduce tissue response and enable precise monitoring and intervention for neurodegenerative conditions. By enhancing brain–machine communication, Axoft seeks to provide more effective treatments for patients with Parkinson's disease and related disorders, supporting tailored therapies and better patient outcomes.

UneMeta

Seed Round in 2022
UneMeta is a curated social platform and marketplace for Non-Fungible Tokens (NFTs), focusing on established intellectual properties and iconic digital assets.

Finwave Semiconductor

Venture Round in 2022
Finwave Semiconductor specializes in the development of advanced gallium nitride (GaN) transistors and integrated circuits (ICs) tailored for 5G communications and power conversion applications. The company utilizes a unique 3DGaN technology, specifically its differentiated fin field-effect transistor (FinFET) design, to enhance the performance of high-volume applications such as radio frequency front end (RFFE) systems for mobile devices. This innovative approach allows Finwave to create semiconductor materials with distinct properties, contributing to advancements in electronics and energy management.

Modern Synthesis

Seed Round in 2022
Modern Synthesis is a biomaterials company focused on developing sustainable, biobased textiles for the fashion industry. By harnessing the capabilities of bacteria, the company creates customizable bio-textiles and composites that serve as eco-friendly alternatives to traditional materials. Their innovative approach utilizes bacterial nanocellulose, recognized for its strength and versatility, to produce textiles that do not rely on petrochemical binders or harmful chemicals. This process allows for the creation of a wide range of aesthetics and functionalities, meeting the diverse needs of designers while eliminating animal inputs. Modern Synthesis is positioned to transform the fashion industry by providing scalable solutions that integrate seamlessly with existing manufacturing practices, thereby reducing reliance on nonrenewable resources and promoting sustainable material usage.

Aspecta

Seed Round in 2022
Aspecta develops technology that links Web2 and Web3 footprints to AI-generated digital identities, delivering an interactive identity ecosystem for builders and others and unlocking data potential. It also operates a digital asset trading platform that enables the exchange of tokens, NFTs and other digital assets, offering bonding curve trading, project asset conversion and real-time market data to support participation in early projects and portfolio management.

WeBox

Series A in 2022
WeBox operates as a cloud kitchen focused on delivering authentic regional Asian cuisine while prioritizing health and quality. The company streamlines its cooking processes by utilizing advanced technology, including NSF-certified cooking robots, to enhance efficiency and maintain consistency in food preparation. WeBox emphasizes the use of high-quality ingredients, such as organic milk and eggs, Berkshire pork, and fresh live seafood, ensuring that its offerings are both healthy and flavorful. In addition to online food delivery, WeBox provides catering services, catering to a diverse range of customer preferences and promoting a savory dining experience.

Cache

Pre Seed Round in 2022
Cache is a biotechnology company focused on developing a groundbreaking wet operating system designed for the storage, access, and computation of biomolecules at scale. By ensuring the integrity and fidelity of nucleic acids from various sources, Cache enables researchers and partners to accelerate molecular pathology research and gain insights into life sciences. This innovative approach facilitates the analysis of biomolecules, thereby unlocking new precision medicine applications and enhancing the capacity for understanding biological data. Ultimately, Cache aims to make both digital and biological data universally accessible and sustainable, eliminating the need for data deletion or disposal.

SanaHeal

Seed Round in 2022
SanaHeal develops bioadhesive medical technologies designed for rapid and strong adhesion to wet and irregular tissue surfaces. Their platform features nature-inspired adhesives modeled after barnacles and spider webs, providing instant drying and secure attachment in moist environments.

Regenerative Bio

Angel Round in 2022
Regenerative Bio is a pioneering biotechnology company focused on anti-aging solutions, utilizing artificial intelligence and cloud supercomputing to revolutionize the field. By integrating AI-driven pharmaceutical technologies with biological research, the company investigates various ingredients, formulations, and therapies aimed at combating the effects of aging. Through its innovative approach, Regenerative Bio seeks to enhance energy metabolism and cellular health, ultimately promoting longer and healthier lives. The firm leverages advanced techniques such as quantum physics and high-throughput preparation to develop cutting-edge anti-aging products and solutions for healthcare professionals.

Revela Health

Seed Round in 2022
Revela is a direct-to-consumer company that discovers novel molecules for consumer health applications and creates better products using these new ingredients.

Kula Bio

Series A in 2022
Kula Bio, Inc. is a biotechnology company focused on developing sustainable solutions for modern agriculture. Founded in 2018 and headquartered in Somerville, Massachusetts, the company specializes in biofertilizers that harness nitrogen-fixing microbes energized by renewable energy sources. This innovative approach allows Kula Bio to produce organic nitrogen fertilizers that aim to replace traditional synthetic fertilizers, promoting both agricultural productivity and environmental stewardship. By enhancing natural microbial processes, Kula Bio’s products enable farmers to improve crop yields while prioritizing sustainability and eco-friendliness in farming practices.

VELOTRIC

Seed Round in 2022
Velotric is a manufacturer of electric bicycles aimed at promoting a sustainable lifestyle with a smaller carbon footprint. The company offers e-bikes equipped with removable batteries, ensuring convenience for users. Velotric provides free shipping on all orders and includes a two-year warranty that covers bike frames, motors, batteries, and controllers for purchased units. Their electric bicycles are designed to be user-friendly, comfortable to ride, and high in performance, while also emphasizing reliability and stylish design. Through its products, Velotric seeks to facilitate a shift towards environmentally friendly transportation options and reduce harmful emissions.

Pantheon Design

Pre Seed Round in 2022
Pantheon Design specializes in creating advanced 3D printing systems aimed at revolutionizing medium-scale manufacturing. The company focuses on developing flexible manufacturing solutions that cater to hardware innovators and integrators. Its printers are designed to deliver end-use quality parts significantly faster and at a lower cost compared to traditional methods. Pantheon Design's technology boasts industry-leading tolerances, superior surface finishes, and mechanical properties, ensuring that clients can produce high-quality products with ease and efficiency. By streamlining the manufacturing process, Pantheon Design addresses the common challenges faced by businesses in the production of parts, ultimately enhancing productivity and reducing costs.

Wetravel

Seed Round in 2021
Wetravel is an online platform that allows organizers of group trips, dance tours, yoga retreats, student excursions, and similar events to create booking pages, collect deposits, and manage payments securely. The service includes features such as automatic image import, traveler data collection, review and post‑trip survey tools, and the ability to export participant information. Organizers can promote their trips through social media and email, and the platform supports international fund transfers at competitive exchange rates. Founded in 2014, Wetravel is headquartered in San Francisco.

Snaplii

Series A in 2021
Snaplii is a digital wallet company focused on transforming the North American fintech landscape. It provides a comprehensive digital payment solution that includes payment, lending, and card-issuing functionalities. Designed to serve both consumers and merchants, Snaplii offers self-issued closed-loop digital credit cards that facilitate traditional payment functions while integrating financial innovations. Additionally, the company features a unique membership and marketing program aimed at enhancing customer engagement, increasing traffic, and boosting sales for its business partners.

Easy Transfer

Series C in 2021
EasyTransfer is a prominent online tuition payment services platform catering to international students and their families. Trusted by over 280,000 users, the company processes more than $3 billion in transactions annually. EasyTransfer partners with major financial entities and serves as the exclusive international education payment service on WeChat. The platform is designed to facilitate cross-border payments, making them as seamless as domestic transactions, with funds often arriving within an hour. It features an intuitive online interface available in the native languages of users, allowing them to manage education payments, compliance paperwork, and track their progress conveniently. With a team of over 100 payment professionals fluent in various languages, EasyTransfer prioritizes transparency by offering real-time bank market exchange rates without markup. The company employs advanced anti-money laundering systems and compliance verification automations, ensuring a secure and efficient service for its clientele.

Signet Therapeutics

Seed Round in 2021
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.

Citcon

Series C in 2021
Citcon is a prominent payment technology company established in 2015, specializing in creating a payment infrastructure that facilitates global merchants in accepting payments from a vast pool of mobile wallet users across various channels, including online, mobile, and in-store. The company's platform offers a secure and user-friendly experience, enhancing contactless shopping and payment processes for consumers and merchants alike. Citcon's open and scalable system enables businesses to seamlessly integrate multiple domestic and international mobile wallets through a single API suite, encompassing comprehensive services from payment processing to fund settlement. Headquartered in Silicon Valley, California, Citcon operates five regional offices across the U.S., Canada, Europe, and Asia, enabling millions of mobile wallet consumers to transact at tens of thousands of merchants worldwide.

Sylvatica Biotech

Seed Round in 2021
Sylvatica Biotech is focused on transforming fields such as organ transplantation, trauma care, oncofertility, and regenerative medicine through innovative cryopreservation technology. The company aims to address the critical limitations associated with organ and tissue preservation, which hinder advancements in transplantation and regenerative medicine. By developing a non-toxic approach to banking human organs, Sylvatica seeks to enable better global organ matching and improve the longevity and availability of organs for transplant. This approach not only has the potential to save or enhance millions of lives worldwide but also offers significant public health benefits. Utilizing strategies inspired by nature, combined with bioengineering principles, Sylvatica Biotech is positioned at the forefront of redefining human health.

ZSFab

Seed Round in 2021
Founded in 2017, ZSFab specializes in manufacturing customized medical implants, surgical guides, and anatomical models. It uses 3D printing technology to create patient-specific products such as hip implants, acetabular cups, vertebral body implants, and surgical guides, aiming to improve surgical outcomes.

XtalPi Technology

Series D in 2021
XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

Nirvana

Seed Round in 2021
Nirvana is an AI-native financial infrastructure shaping the future of Agentic DeFi. - Redefining DeFi with AI Agents – Nirvana builds AI frameworks for DEFAI agents to maximize capital efficiency - AI-Native On-Chain Protocols – Empowering DEFAI agents with AI-native protocols to autonomously launch innovative financial instruments and optimize strategies

Relativity Space

Series E in 2021
Founded in 2015, Relativity Space is a pioneering aerospace company based in Long Beach, California. It specializes in manufacturing and launching orbital rockets using proprietary 3D printing technology, significantly reducing the number of parts and assembly time compared to traditional methods.

Bioz

Series A in 2021
Bioz Inc. is a technology company based in Palo Alto, California, specializing in cloud-based applications that utilize natural language processing (NLP) to aid scientific researchers. Established in 2013, Bioz operates a platform that serves as a search engine specifically for life science experimentation, allowing researchers in academia and biopharma to efficiently identify and compare reagents, instruments, and consumables for their experiments. The platform employs advanced AI to analyze data from the materials and methods sections of peer-reviewed articles, providing relevancy rankings, product ratings, and collaborative insights. By streamlining the process of finding and selecting appropriate scientific products, Bioz aims to accelerate drug discovery and enhance the success rate of finding cures for various diseases.

ProteoWise

Venture Round in 2021
Founded in 2018 by scientists from Yale University's Strittmatter Lab, ProteoWise specializes in developing innovative proteomic technology. Its flagship product is a 3D nanoscale protein capturing material that simplifies western blot analysis while providing high information content and throughput at a low cost.

Databento

Convertible Note in 2021
Databento is a company that specializes in providing streamlined access to financial market data. Founded by experienced traders and engineers from renowned quantitative hedge funds, Databento offers a self-service platform that allows users to quickly obtain live exchange feeds and extensive historical data. The platform automates data licensing and minimizes onboarding time, making it easier for businesses and financial institutions to access high-quality, institutional-grade data directly from the source. Databento's servers are strategically located in colocation facilities at various trading venues, ensuring low-latency and reliable data capture. Users can choose between a pay-as-you-go model or flat-rate pricing, allowing them to manage costs effectively according to their data usage needs.

Cardea Bio

Series A in 2021
Cardea Bio, Inc. is a biotechnology company based in San Diego, California, focused on developing and commercializing bioelectronics for research and diagnostics. Established in 2013, Cardea utilizes proprietary graphene-based digital biosensors to create advanced biosensor hardware, software, and molecular infrastructure, enabling precision healthcare through improved diagnostic capabilities. The company's product offerings include the AGILE R100, an innovative assay for drug discovery, and the AGILE R200, an automated high-throughput screening solution. Cardea's biosensors convert biomolecular interactions into digital data, allowing for real-time biological signal analysis and access to streaming multi-omics data. Their solutions cater to various applications in life sciences and healthcare, such as small molecule validation, antibody characterization, and biomolecular analysis.

SnapPay

Seed Round in 2021
SnapPay is a prominent payment platform in North America, facilitating the acceptance of Alipay, WeChat Pay, and China UnionPay for merchants. The company specializes in providing a secure environment for online, in-store, in-app, and mobile transactions, ensuring safe payment processes for both businesses and consumers. In addition to its payment services, SnapPay offers marketing solutions that help merchants reach new customers and increase revenue across various channels. By enabling simple and secure one-touch payments, SnapPay enhances the overall payment experience for users, streamlining the transaction process for businesses and their clientele.

Virgin Hyperloop

Venture Round in 2021
Hyperloop One, Inc. is focused on the design and development of a high-speed tubular transit system that employs magnetic levitation technology to facilitate the rapid transportation of passengers and cargo. Founded in 2014 and headquartered in Los Angeles, California, the company aims to provide direct and sustainable transportation solutions. Hyperloop One's innovative system allows for speeds of up to 760 miles per hour, utilizing a vacuum tube to optimize travel efficiency. The company collaborates with various partners, including renowned firms such as Parsons, ARUP, and McKinsey, to enhance its technology and implementation strategies. Originally known as Hyperloop Technologies, Inc., the company rebranded in May 2016 to reflect its evolving mission within the transportation sector.

TheraDep

Venture Round in 2021
TheraDep specializes in the development of advanced surface coatings for microneedles and labware, focusing on applications in the medical device and pharmaceutical sectors. The company offers biocompatible, drug-eluting, growth-promoting, and therapeutic coatings, utilizing a novel patented process. By collaborating with medical device and labware manufacturers, TheraDep provides customized solutions that address specific needs in drug delivery and patient treatment, enhancing the effectiveness and safety of medical applications.

Landsdowne

Venture Round in 2021
Landsdowne specializes in developing and commercializing innovative battery technology. Their primary product is a safety-focused solution designed to deactivate button batteries following accidental ingestion, aiming to mitigate the growing health crisis associated with these batteries.

OnePiece Work

Seed Round in 2021
OnePiece Work is a global tech community that operates coworking spaces designed to foster collaboration and innovation across various industries. Founded with the mission to create an inclusive environment, OnePiece Work addresses the challenges faced by professionals, particularly those from minority backgrounds, in feeling a sense of belonging in the workplace. The company provides flexible workspace solutions, including meeting rooms and comfortable workstations, alongside strategic consultation and support for startups. By partnering with over 250 companies across more than 30 industries, OnePiece Work has established itself as a vital platform for personal and professional growth, enabling its members to create, collaborate, and thrive in a supportive atmosphere.

Enrich Biosystems

Pre Seed Round in 2021
Enrich Biosystems develops a microfluidics-free platform for cell imaging, analysis, and capture to advance cell-based therapies, precision medicine, and other life science applications. It provides single-cell isolation technology that operates without fluidics, using dissolvable microwells and visual enrichment strategies to simplify workflows for cell culturing, kinetics profiling, and function-based capture, enabling streamlined research and more precise study of cellular behavior.

MuMec

Seed Round in 2021
MuMec develops wireless transceiver technologies that significantly reduce operating power for use in Bluetooth low energy and LoRa/Sigfox protocols. Founded in 2014, the company is headquartered in Oakland, California.

New Frontier Bio

Seed Round in 2021
New Frontier Bio is a biotechnology company headquartered in Beverly, Massachusetts, established in 2020. The company focuses on developing consumer health products aimed at reversing the signs of aging and enhancing natural health and lifespan at the cellular level. Its product line includes skin health solutions and dietary supplements formulated from a natural compound known for promoting skin longevity. By addressing the challenges of aging, New Frontier Bio seeks to improve the quality of life for consumers through innovative health products.

Altrixbio

Seed Round in 2021
Altrixbio develops therapeutic drugs designed for controlled gastrointestinal targeting. Its flagship product, LuCIâ„¢, is an oral drug that mimics the effects of gastric bypass surgery in Type 2 diabetes patients by providing duodenal isolation and restricting fat and glucose absorption.

Concerto Biosciences

Seed Round in 2020
Concerto Biosciences develops microbe-based products that rebuild microbial communities in and around humans and ecosystems. The company uses an ultra-high-throughput platform to experimentally measure millions of microbial interactions and map interaction networks, enabling the discovery of ensembles, which are specific combinations of microbes that work together to shepherd damaged microbial communities back to health. These ensembles have potential applications across medicine and agriculture, addressing global challenges in health, food, and industry. By focusing on microbial community engineering, Concerto aims to become a leading inventor of ensembles and to redefine how microbiomes are leveraged for health and environmental outcomes.

Manus Bio

Series B in 2020
Manus Bio Inc. is a biotechnology company that specializes in recreating plant processes in microorganisms to produce natural ingredients through advanced fermentation technology. Founded in 2011 and based in Cambridge, Massachusetts, the company utilizes a combination of metabolic engineering, protein engineering, and systems biology to develop microbes capable of generating a variety of plant-based ingredients. These ingredients have diverse applications, including flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals, and agricultural chemicals. Manus Bio operates manufacturing facilities in Cambridge and Augusta, Georgia, and has established a strategic partnership with BBGI Public Company Limited. The company was previously known as Manus Biosynthesis, Inc. before changing its name in June 2018.

PointCloud

Seed Round in 2020
PointCloud is a technology company that specializes in developing a 3D imaging platform on a chip, focusing on high-performance 4D imaging solutions. The company's innovative technology employs big data analytics and machine learning to analyze 3D point clouds, which enhances applications in augmented reality, robotics, and autonomous mobility. By leveraging these advanced capabilities, PointCloud aims to provide users with a clearer and more interactive understanding of their environments, facilitating significant advancements in various technological fields.

Cardea Bio

Series A in 2020
Cardea Bio, Inc. is a biotechnology company based in San Diego, California, focused on developing and commercializing bioelectronics for research and diagnostics. Established in 2013, Cardea utilizes proprietary graphene-based digital biosensors to create advanced biosensor hardware, software, and molecular infrastructure, enabling precision healthcare through improved diagnostic capabilities. The company's product offerings include the AGILE R100, an innovative assay for drug discovery, and the AGILE R200, an automated high-throughput screening solution. Cardea's biosensors convert biomolecular interactions into digital data, allowing for real-time biological signal analysis and access to streaming multi-omics data. Their solutions cater to various applications in life sciences and healthcare, such as small molecule validation, antibody characterization, and biomolecular analysis.

Butlr

Seed Round in 2020
Butlr Technologies Inc. is a technology company based in Burlingame, California, that specializes in wireless sensor devices designed to collect and transmit real-time data. The company's innovative technology utilizes body heat to detect occupancy, headcount, body posture, and activity, offering accurate spatial insights for various industries, including retail, hospitality, healthcare, and sustainable building management. By analyzing location and duration data, Butlr helps optimize retail space layout and enhances understanding of consumer behavior and preferences. Incorporated in 2019, Butlr is focused on providing efficient solutions that improve operational effectiveness and customer experiences.

Galixir

Seed Round in 2020
Galixir is a United States-based company that specializes in artificial intelligence-driven drug research and development. Founded in 2019, it provides an advanced platform that aids pharmaceutical companies by streamlining various stages of drug development, including retrosynthesis prediction, synthetic design, and drug screening. Utilizing cutting-edge technologies in artificial intelligence, chemical engineering, computational biology, and cloud computing, Galixir aims to significantly reduce the time and costs associated with drug development. Additionally, the platform offers comprehensive patent protection coverage for the drugs developed, enhancing the overall value of its services to clients engaged in the pharmaceutical industry.

Kula Bio

Seed Round in 2020
Kula Bio, Inc. is a biotechnology company focused on developing sustainable solutions for modern agriculture. Founded in 2018 and headquartered in Somerville, Massachusetts, the company specializes in biofertilizers that harness nitrogen-fixing microbes energized by renewable energy sources. This innovative approach allows Kula Bio to produce organic nitrogen fertilizers that aim to replace traditional synthetic fertilizers, promoting both agricultural productivity and environmental stewardship. By enhancing natural microbial processes, Kula Bio’s products enable farmers to improve crop yields while prioritizing sustainability and eco-friendliness in farming practices.

LASE Innovation

Series A in 2020
LASE Innovation Inc. is a company based in Cambridge, Massachusetts, that specializes in the development and commercialization of advanced laser particle technology. Founded in 2018, it focuses on creating light-emitting particles ranging from nano to micron sizes, primarily targeting the life sciences and diagnostic markets. The company's innovative technology utilizes billions of spectral barcodes, enabling massively multiplexed tagging and imaging of single cells. This advancement significantly enhances researchers' capabilities by providing orders of magnitude improvements over conventional fluorescent probes, thus facilitating more effective multiplexing and cell tracking applications.

BluWhale

Pre Seed Round in 2019
BluWhale is a technology company based in the United States that specializes in developing artificial intelligence solutions for business intelligence software as a service. The company aims to automate LiveOps and optimize revenue for its clients, particularly in the gaming industry. By harnessing artificial intelligence and machine learning, BluWhale enables game developers to concentrate on enhancing their games rather than managing and interpreting vast quantities of data. Its smart automation technology performs the complex analysis typically carried out by data analysts and data scientists, delivering actionable insights seamlessly in the background.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.